HAVCR2 and acute myeloid leukemia: In addition, the team demonstrated that the bone marrow microenvironment induced the upregulation of TIM3 and Gal-9 expression, and thus they concluded that the TIM3-Gal-9 signaling axis may contribute to MDS disease progression and transformation to AML.